Dow Rockets 912 Points Higher on Vaccine Hopes

The first early clinical results from the first vaccine candidate in human testing, a drug from Moderna (ticker: MRNA), showed promise, sparking a broad rally on Wall Street. It's undoubtedly a positive sign, and accompanied by an emphatic weekend interview from Federal Reserve Chairman Jerome Powell vowing as much central bank help for markets as was necessary, investors bid markets much higher on the dual dose of optimism. The news from Moderna sent MRNA shares up 20% as the company touted dat